Turn this role into an interview — a resume and cover letter built around what this employer wants.
Zealand Pharma A/S seeks a Regulatory Documentation Specialist to drive submission operations across CTA/IND/MAA/PIP, ensuring timely, high-quality documents. The role interfaces with RA and cross-functional teams to maintain trackers and CTIS processes.
You will coordinate with CROs, publishers and external partners, manage DSUR IB QA activities and support archiving in Veeva RIM. Fluency in English and meticulous attention to detail are essential.
Does it excite you to keep regulatory submissions on track for one of the industry's most closely watched obesity programs, and do you have a talent for turning cross-functional input into submission-ready documentation? If this sounds like you, and you are ready to take on a broad area of responsibilities across our clinical pipeline, then you could be our new colleague.
As our new Regulatory Documentation Specialist, you will support the petrelintide projects, driving the operational delivery of CTA/IND/NDA/MAA/PIP and meeting package submissions. You will be the operational backbone of our submission management process, working closely with RA and cross-functional colleagues, and external stakeholders to ensure high-quality, submission-ready documents. This is a role for someone who thrives on structure, detail, and keeping regulatory activities on track.
You are structured, collaborative and proactive, with a natural ability to keep multiple stakeholders and moving parts aligned toward a shared deadline. You take ownership of your tasks, communicate clearly across functions, and stay calm and organized even when submission timelines are tight.
You will join RA Clinical Petrelintide with 6 highly skilled Regulatory Affairs colleagues. The department is one of the five departments within Regulatory Affairs & Medical Writing.
We have a unique culture, characterized by excellent teamwork and strong engagement across the organization. And we want you to help us strengthen this culture.
Making bonds is at the core of everything we do. From discovering and developing the best new peptide drugs for patients, to engaging with our partners or connecting with each other. We bond through curiosity and playfulness as a team, allowing ourselves to challenge common thinking and drive future innovation. Join us and let's bond and be bold.
For further information, please contact Senior Director, Head of RA Clinical Petrelintide, Susanne Lund Olsen , slolsen@zealandpharma.com .
We are committed to an inclusive recruitment process and welcome applications from all job applicants.
Zealand Pharma A/S (Nasdaq: ZEAL) is a biotechnology company focused on advancing medicines for obesity and metabolic health. Combining more than 25 years of peptide R&D expertise with a proprietary data platform that leverages advanced data-driven and AI/ML approaches, Zealand Pharma aims to lead a new era in obesity and metabolic health. To date, more than ten Zealand Pharma-invented drug candidates have entered clinical development, of which two products have reached the market and three candidates are in late-stage development. The Company has collaborations with global pharmaceutical and biotechnology partners for research, development, and commercialization. Founded in 1998, Zealand Pharma is headquartered in Copenhagen, Denmark, with a U.S. presence in Boston, Massachusetts. Learn more at www.zealandpharma.com.
#LI-Onsite